Alexander Greystoke - 07 May 2023 Form 4 Insider Report for Israel Acquisitions Corp (ISRL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
09 May 2023, 16:55:22 UTC
Prior SEC filing
19 Jan 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alex Greystoke

Key filing fact

Alexander Greystoke filed Form 4 for Israel Acquisitions Corp (ISRL) on 09 May 2023.

Key facts

  • This page summarizes Alexander Greystoke's Form 4 filing for Israel Acquisitions Corp (ISRL).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 09 May 2023, 16:55.

Change

  • Previous filing in this sequence was filed on 19 Jan 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISRL transaction Derivative

Class B ordinary shares, par value $0.0001

Sale

Transaction value
Shares
-95,900
Change %
-2%
Price
Shares after
4,696,167
Date
07 May 2023
Ownership
See Footnote
Underlying class
Class A ordinary shares, par value $0.0001
Underlying amount
95,500
Exercise price
Footnotes
F1, F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Class B ordinary shares, par value $0.0001 per share (the "Class B Ordinary Shares"), of Israel Acquisitions Corp (the "Issuer") are convertible into Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares") of the Issuer upon either the consummation of the Issuer's initial business combination or earlier, at the option of the holder. The Class B Ordinary Shares have no expiration date.

Footnote F2

Pursuant to that certain securities assignment agreement (the "Securities Assignment Agreement"), effective as of May 7, 2023, by and between the Issuer's sponsor, Israel Acquisitions Sponsor LLC (the "Sponsor"), and Mr. Aaron Greenberg, the Sponsor agreed to assign and sell 95,500 shares of Class B Ordinary Shares to Mr. Aaron Greenberg for $9.55 (the "Purchased Shares").

Footnote F3

As part of the Securities Assignment Agreement, Mr. Greenberg agreed (i) that the Purchased Shares are subject to the restrictions (including the lock-up restrictions) and obligations as set forth in that certain Securities Subscription Agreement dated January 22, 2022, by and between the Sponsor and the Issuer; (ii) to be a party to that certain letter agreement, dated January 12, 2023, by and between the Issuer and Mr. Greenberg and filed as Exhibit 10.1 to the Issuer's Form 8-K, filed on January 19, 2023; and (iii) that Mr. Greenberg will assign the Purchased Shares to the Sponsor as of the earlier of (a) the date of the Issuer's initial business combination if, as of such date, Mr. Greenberg has not been principally engaged as an advisor to the Issuer during the 30 days prior to such date or (b) the liquidation of the Issuer, if such liquidation occurs.

Footnote F4

These Class B Ordinary Shares are held directly by the Sponsor. The managers of the Sponsor are the Reporting Person and Mr. Charles Ecalle. The Reporting Person and Mr. Ecalle have voting and dispositive power over the securities held by the Sponsor and each disclaim beneficial ownership over any securities owned by the Sponsor in which the Reporting Person and Mr. Ecalle, respectively, do not have a pecuniary interest.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .